DCX and neoplasm: Encouragingly, although ACT-DC did not greatly improve the RT effects as compared to RT alone (Supplementary Fig. 41), a combination of RT, ACT-DC, and aPD1 led to tumor regression in 50% of the treated mice (Fig. 7b).